Trade Summary

1 week ago, TETRAULT LYNN A., serving as Dir at NEOGENOMICS INC (NEO), sold 5,307 shares at $11.29 per share, for a total transaction value of $59,916.03. Following this transaction, TETRAULT LYNN A. now holds 91,422 shares of NEO.

This sale represents a 5.49% decrease in TETRAULT LYNN A.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, June 9, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, June 11, 2026 at 4:10 PM ET, 2 days after the trade was made.

NEOGENOMICS INC operates in the HEALTHCARE sector, specifically within the DIAGNOSTICS & RESEARCH industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.